Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

ClinicalTrials.gov ID: NCT00003614

Public ClinicalTrials.gov record NCT00003614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Weekly Paclitaxel by 1-HR Infusion Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma

Study identification

NCT ID
NCT00003614
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • estramustine phosphate sodium Drug
  • paclitaxel Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 3, 1999
Primary completion
Mar 31, 2005
Completion
Not listed
Last update posted
Jun 14, 2023

Started 1999

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
21
Facility City State ZIP Site status
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago Illinois 60611
Veterans Affairs Medical Center - Chicago (Lakeside) Chicago Illinois 60611
CCOP - Central Illinois Decatur Illinois 62526
CCOP - Illinois Oncology Research Association Peoria Illinois 61602
CCOP - Carle Cancer Center Urbana Illinois 61801
Indiana University Hospitals Indianapolis Indiana 46202
Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis Indiana 46202
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Ochsner New Orleans Louisiana 70121
New England Medical Center Hospital Boston Massachusetts 02111
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07018-1095
CCOP - Northern New Jersey Hackensack New Jersey 07601
University of Rochester Cancer Center Rochester New York 14642
CCOP - Merit Care Hospital Fargo North Dakota 58122
Ireland Cancer Center Cleveland Ohio 44106-5065
CCOP - Geisinger Clinical and Medical Center Danville Pennsylvania 17822-2001
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
CCOP - MainLine Health Wynnewood Pennsylvania 19096
Veterans Affairs Medical Center - Madison Madison Wisconsin 53705
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792
Medical College of Wisconsin Milwaukee Wisconsin 53226
Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee Wisconsin 53295

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003614 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →